BCG stands for Bacillus Calmette-Guérin, a weakened form of the bacteria that causes tuberculosis. When used for bladder cancer, it’s an immunotherapy delivered directly into the bladder, where it activates your immune system to recognize and attack cancer cells. It’s been used in urology for decades, and urinary oncologists and urologists regularly turn to it […]

New five-year data from the phase III CheckMate 274 trial is giving patients and doctors more confidence in using nivolumab (Opdivo) after surgery for high-risk muscle-invasive urothelial carcinoma, the most common type of bladder cancer. Researchers found that patients who received nivolumab after surgery stayed cancer-free significantly longer than those who didn’t receive the treatment. […]

Some cancers run in families. About 5 to 10 out of every 100 cancers happen because of a gene change that is passed down from a parent. A gene change like this is called a “pathogenic variant”, which means a change in a gene that can raise your risk of getting cancer. When a cancer […]